# OnCo record utr-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/utr-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "utr-therapeutics" ;
  schema:name "UTR Therapeutics"@en ;
  schema:alternateName "UTR Therapeutics Inc."@en, "UTRx Inc."@en ;
  schema:description "UTR Therapeutics is a New York company making RNA medicines that make a cancer-driving gene's message break down before it can be made into protein. Its sarcoma medicine, UTRxMYCN M1-14, aims at MYCN, a cancer gene that ordinary drugs cannot grip."@en ;
  schema:url <https://onco.cc/companies/utr-therapeutics/>, <https://www.utrtherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.utrtherapeutics.com/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1182626> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/rhabdomyosarcoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/antisense-sirna/> ;
  onco:targets <https://onco.cc/targets/mycn/> ;
  onco:drugs <https://onco.cc/drugs/utrxmycn-m1-14/> .